|
End-of-day quote
New Zealand S.E.
08/09/2026
|
5-day change | 1st Jan Change | ||
| 4.310 NZD | -0.69% |
|
-2.27% | +27.51% |
| 09/09 | Aft Pharmaceuticals Limited Partners with Mark Cuban Cost Plus Drug Company to Bring Combogesic to the U.S | CI |
| 31/07 | AFT Pharmaceuticals Limited - Shareholder/Analyst Call |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- AFT Stock
- Consensus AFT Pharmaceuticals Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
